Showing results (311-320 of 1,014) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|February 24, 2026
Subclassification of Small Cell Lung Cancer Based on Gene Expression Signatures and Machine LearningNicole Kiedanski, Julian Kreis, Lucia Spangenberg, et al.
Cancer Research Communications|March 6, 2026
The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trialJoanne B Weidhaas, Jonathan Harris, Maura L Gillison, et al.
Cancer Research Communications|February 19, 2026
Collagen-bearing exosomes from breast cancer-associated fibroblasts promote T cell dysfunctionSamir Jana, Matthew Lawton, Pin-Ji Lei, et al.
Cancer Research Communications|February 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 StudyStephen L Chan, Thomas Yau, Robin K Kelley, et al.
Cancer Research Communications|March 16, 2023
Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar CarcinomaAdam B Francisco, Jine Li, Alaa R Farghli, et al.
Cancer Research Communications|March 16, 2023
A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA VaccinationMatthias Birtel, Ralf-Holger Voss, Katharina Reinhard, et al.
Cancer Research Communications|March 16, 2023
Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy-induced MetastasisVictoria Hoskin, Abdi Ghaffari, Brian J Laight, et al.
Cancer Research Communications|March 20, 2023
Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse ModelsBoris Shorning, Neil Trent, David F Griffiths, et al.
Cancer Research Communications|April 17, 2023
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune ToleranceZoë Johnson, Chiara Tarantelli, Elisa Civanelli, et al.
Cancer Research Communications|April 20, 2023
RAB27B Drives a Cancer Stem Cell Phenotype in NSCLC Cells Through Enhanced Extracellular Vesicle SecretionKayleah M Meneses, Prita Pandya, Jennifer A Lindemann, et al.
Pageof 102